Association between increased serum IL-23 levels and ACPA positivity in patients with rheumatoid arthritis

Clin Exp Rheumatol. 2023 May;41(5):1198-1199. doi: 10.55563/clinexprheumatol/1yfr4z. Epub 2023 Jan 31.

Authors

Hiroki Kohno¹, Tomohiro Sugimoto², Yusuke Yoshida², Sho Mokuda², Shintaro Hirata², Eiji Sugiyama²

Affiliations

¹ Department of Rheumatology, Medical Corporation JR Hiroshima Hospital; and Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan. hirkohno@hiroshima-u.ac.jp.
² Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.

PMID: 36719739
DOI: 10.55563/clinexprheumatol/1yfr4z

No abstract available

Publication types

Letter

MeSH terms

Arthritis, Rheumatoid* / diagnosis
Autoantibodies
Humans
Interleukin-23
Rheumatoid Factor

Substances

Rheumatoid Factor
Interleukin-23
Autoantibodies